welcome to the video journal of hematology & hematological oncology 🎥🩸
Published 1 month ago • 328 plays • Length 3:08Download video MP4
Download video MP3
Similar videos
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
3:31
update on quantum-first: quizartinib soc chemotherapy & as continuation therapy in flt3-itd aml
-
1:44
updates from the phase ii animate trial of nivolumab in r/r chl
-
1:43:48
speciality update with hematologists
-
7:01
hvac air duct making machine / duct manufacture line / auto duct line â…²
-
31:06
novel biomarker module six - result interpretation
-
4:37
updates from uk ncri aml18
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
4:16
updates from amg 330 in aml
-
2:14
update on the aml treatment landscape
-
0:53
go-flag: bridge therapy to allo-sct in r/r aml
-
2:41
an overview of the latest advances in hematology
-
0:49
the future of inhibiting bcl2 for the treatment of t-all
-
5:13
phase ii trial of pembrolizumab prior to allo-sct in aml
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
2:43
gemtuzumab ozogamicin in frontline aml therapy
-
8:57
outcomes of sct in t-all and t-lbl
-
0:47
overview of the phase iii enhance trial schema